AMEX · Medical - Devices

Phaos Technology Holdings (Caym (POAS) Stock

$0.18 -3.79% AMEX: POAS Healthcare

Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore.

Valuation

MetricValue
Price$0.18
Market Cap$2.47M
P/E Ratio-0.59
P/B Ratio-1.56
P/S Ratio18.81
EPS (TTM)$-0.39
52-Week High$7.40
52-Week Low$0.17
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE250.00%
ROA-265.61%
ROCE283.60%
Gross Margin22.10%
Operating Margin-31.48%
Net Margin0.00%
Debt/Equity-0.14
Current Ratio0.40

Annual Financials (USD)

Metric202220232024
Revenue$1.0M$2.0M$0
Operating Profit$-2.0M$-3.0M$-5.0M
Net Profit$-2.0M$-2.0M$-5.0M
EPS$-0.13$-0.18$-0.39
Op Margin-313.8%-132.9%-3148.3%

Balance Sheet (USD)

Metric202220232024
Total Assets$1.0M$5.0M$2.0M
Total Liabilities$4.0M$2.0M$4.0M
Cash$0$2.0M$0
Borrowings$1.0M$1.0M$0

Latest News

Phaos Technology Holdings (Cayman) Limited Provides Updated Response to Unusual Market Action GlobeNewswire · Jun 3, 2026

Cash Flow (USD)

Metric202220232024
Operating Cash Flow$-2.0M$-2.0M$-4.0M
Investing Cash Flow$0$-2.0M$-1.0M
Financing Cash Flow$0$-3.0M$-1.0M
Net Cash Flow$0$2.0M$-2.0M
Free Cash Flow$-2.0M$-2.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.67
FCF Yield-123.21%
Quick Ratio0.32
Interest Coverage-623.88
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held36.41%
Institutions Held2.26%
Institutions Float Held3.55%
Institutional HolderSharesReport Date
UBS Group AG22,6422026-03-31
HRT Financial LP119,2152026-03-31
Renaissance Technologies, LLC14,1002026-03-31
Xtx Topco Ltd153,1132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CV $6.63 +0.15% -6.45 $331.26M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
HYPR $0.94 +0.99% -3.44 $78.94M 0.00%
MIAX $47.04 +2.26% -53.31 $4.55B 0.00%
MXCT $1.18 +6.31% -2.55 $126.40M 0.00%

About Phaos Technology Holdings (Caym

Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.

Phaos Technology Holdings (Caym is led by CEO Hong Loon Gan, employs 25 people, headquartered in SG, publicly traded since 2025.

Phaos Technology Holdings (Caym (POAS) stock trades at $0.18 with a market capitalization of $2.47M. The stock is valued at a price-to-earnings (P/E) ratio of -0.59, price-to-book of -1.56, price-to-sales of 18.81. Over the past 52 weeks the stock has ranged between $0.17 and $7.40, and currently trades 97.6% below its 52-week high.

On profitability, Phaos Technology Holdings (Caym generates a return on equity (ROE) of 250.00% — well above the market average, a sign of a high-quality business, return on capital employed of 283.60%, an operating margin of -31.48%, a net profit margin of 0.00%.

Official website: phaostech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides